S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Better Than Oil Stocks (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
The perfect AI stock under $10 (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Better Than Oil Stocks (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
The perfect AI stock under $10 (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Better Than Oil Stocks (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
The perfect AI stock under $10 (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Better Than Oil Stocks (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
The perfect AI stock under $10 (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
NASDAQ:HOLX

Hologic (HOLX) Stock Price, News & Analysis

$76.15
+0.27 (+0.36%)
(As of 02/23/2024 ET)
Today's Range
$75.64
$76.48
50-Day Range
$70.32
$76.15
52-Week Range
$64.02
$87.88
Volume
1.42 million shs
Average Volume
2.00 million shs
Market Capitalization
$17.87 billion
P/E Ratio
36.09
Dividend Yield
N/A
Price Target
$86.89

Hologic MarketRank™ Stock Analysis

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
14.1% Upside
$86.89 Price Target
Short Interest
Healthy
1.94% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.59
Upright™ Environmental Score
News Sentiment
1.03mentions of Hologic in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$1.81 M Sold Last Quarter
Proj. Earnings Growth
8.46%
From $4.02 to $4.36 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.67 out of 5 stars

Medical Sector

68th out of 936 stocks

Medical Instruments & Supplies Industry

2nd out of 2 stocks


HOLX stock logo

About Hologic Stock (NASDAQ:HOLX)

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HOLX Stock Price History

HOLX Stock News Headlines

The Retirement of Your Dreams Awaits You…
Imagine it's 2025 and you have the financial freedom to pursue any of your biggest goals. All of this because YOU decided to take action in 2024. The Bitcoin Halving in 2024 could change your life forever...And the strategies outlined in the Crypto Retirement Blueprint will give you what you need to be able to crush the upcoming halving cycle bull run, and potentially retire quickly in wealth.
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)
Hologic (NASDAQ:HOLX) Downgraded to Hold at StockNews.com
HOLX Mar 2024 50.000 put
HOLX Mar 2024 70.000 put
Hologic, Inc.
Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
Hologic: Prospects For Growth As Headwinds Disappear
Hologic First Quarter 2024 Earnings: Beats Expectations
Hologic price target raised by $2 at Morgan Stanley, here's why
Hologic: Hold Rating Justified by Solid Performance and Fair Valuation
Q1 2024 Hologic Inc Earnings Call
Recap: Hologic Q1 Earnings
Hologic Inc Q1 Profit Increases, beats estimates
See More Headlines
Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/01/2024
Today
2/25/2024
Next Earnings (Estimated)
5/06/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
X-ray apparatus & tubes
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:HOLX
CUSIP
43644010
Employees
6,990
Year Founded
1985

Price Target and Rating

Average Stock Price Target
$86.89
High Stock Price Target
$105.00
Low Stock Price Target
$72.00
Potential Upside/Downside
+14.1%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

Net Income
$456 million
Pretax Margin
15.83%

Debt

Sales & Book Value

Annual Sales
$4.03 billion
Cash Flow
$5.34 per share
Book Value
$19.83 per share

Miscellaneous

Free Float
230,624,000
Market Cap
$17.87 billion
Optionable
Optionable
Beta
1.02

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Should I Buy Hologic Stock? HOLX Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Hologic was last updated on Tuesday, February 20, 2024 at 3:25 PM.

Pros

Here are some ways that investors could benefit from investing in Hologic, Inc.:

  • Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health, which is a growing market segment with increasing demand.
  • Recent developments in the company's product portfolio have shown innovation and competitiveness in the healthcare industry.
  • Hologic, Inc. has a strong distribution network that includes healthcare facilities, resources, independent distributors, and sales representatives, providing a wide reach for its products.
  • The current stock price of Hologic, Inc. is competitive and shows potential for growth based on recent financial performance.

Cons

Investors should be bearish about investing in Hologic, Inc. for these reasons:

  • While the company has shown innovation, there may be risks associated with new product development and market acceptance.














HOLX Stock Analysis - Frequently Asked Questions

Should I buy or sell Hologic stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HOLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HOLX, but not buy additional shares or sell existing shares.
View HOLX analyst ratings
or view top-rated stocks.

What is Hologic's stock price target for 2024?

8 brokerages have issued 1 year price targets for Hologic's shares. Their HOLX share price targets range from $72.00 to $105.00. On average, they anticipate the company's stock price to reach $86.89 in the next year. This suggests a possible upside of 14.1% from the stock's current price.
View analysts price targets for HOLX
or view top-rated stocks among Wall Street analysts.

How have HOLX shares performed in 2024?

Hologic's stock was trading at $71.45 at the beginning of 2024. Since then, HOLX shares have increased by 6.6% and is now trading at $76.15.
View the best growth stocks for 2024 here
.

Are investors shorting Hologic?

Hologic saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 4,490,000 shares, a decrease of 20.1% from the January 15th total of 5,620,000 shares. Based on an average daily trading volume, of 1,930,000 shares, the days-to-cover ratio is currently 2.3 days. Approximately 1.9% of the shares of the company are short sold.
View Hologic's Short Interest
.

When is Hologic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our HOLX earnings forecast
.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) released its earnings results on Thursday, February, 1st. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.03. The medical equipment provider had revenue of $1.01 billion for the quarter, compared to analyst estimates of $989.32 million. Hologic had a trailing twelve-month return on equity of 18.91% and a net margin of 12.98%. The firm's revenue for the quarter was down 5.7% on a year-over-year basis. During the same period last year, the company posted $1.07 EPS.
Read the conference call transcript
.

What guidance has Hologic issued on next quarter's earnings?

Hologic updated its FY 2024 earnings guidance on Thursday, February, 1st. The company provided EPS guidance of 3.970-4.120 for the period, compared to the consensus estimate of 4.000. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 billion.

What is Steve MacMillan's approval rating as Hologic's CEO?

447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

Who are Hologic's major shareholders?

Hologic's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.79%), Victory Capital Management Inc. (2.15%), Price T Rowe Associates Inc. MD (1.51%), Norges Bank (1.30%), Parnassus Investments LLC (1.23%) and Northern Trust Corp (1.15%). Insiders that own company stock include Benjamin Jordan Cohn, Essex D Mitchell, Jan Verstreken, John M Griffin, Karleen Marie Oberton, Scott T Garrett, Sean S Daugherty and Sean S Daugherty.
View institutional ownership trends
.

How do I buy shares of Hologic?

Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Hologic have any subsidiaries?
The following companies are subsidiares of Hologic: Acessa Health, Acessa Health Inc., Beijing Hologic Technology Co. Ltd., Benassar Diagnostica-Equipamientos Medicos Unipessoal Lda., BioLucent, BioLucent LLC, Bioptics Inc., Biotheranostics Inc, Biotheranostics Inc., Bolder Surgical, Cynosure, Cytyc, Cytyc Corporation, Cytyc Prenatal Products Corp., Cytyc Surgical Products LLC, Diagenode Co. Ltd., Diagenode LLC, Diagenode SA, Diagenode SA., Diagenode SPA, Direct Radiography Corp., Emsor Sociedad de responsabilidad limitada, Faxitron Bioptics, Faxitron Bioptics LLC, Focal Therapeutics, Gen-Probe, Gen-Probe Incorporated, Gen-Probe Prodesse Inc., Gen-Probe Sales & Service Inc., Genewave SAS, Health Beacons Inc, Health Beacons Inc., Hologic (Australia & New Zealand) Pty Ltd., Hologic (MA) LLC, Hologic (Shanghai) Medical Supplies Co. Ltd., Hologic ASE LLC, Hologic Asia Limited, Hologic Asia Pacific Limited, Hologic Austria GmbH, Hologic BV, Hologic Bermuda Limited, Hologic Canada ULC, Hologic Caribbean (Barbados) SRL, Hologic Denmark ApS, Hologic Deutschland GmbH, Hologic Espana S.A., Hologic Finance Ltd., Hologic France SARL, Hologic GGO 2 LLC, Hologic GGO 3 LLP, Hologic GGO 4 LTD, Hologic Global Holding LTD, Hologic HUB LTD, Hologic Hitec-Imaging, Hologic Hitec-Imaging GmbH, Hologic Holdings Limited, Hologic IP LTD, Hologic Iberia S.L., Hologic India LLP, Hologic International Holdings B.V., Hologic Ireland Limited, Hologic Italia S.r.l., Hologic Japan KK, Hologic Latin America (Servicos Em Marketing E Negocios) Ltda., Hologic Ltd., Hologic Malaysia SDN. BHD., Hologic Medical Technologies (Beijing) Co. Ltd., Hologic Medicor GmbH, Hologic Medicor Suisse GmbH, Hologic Netherlands B.V., Hologic Nordic Holdings Oy, Hologic Singapore Pte. Ltd, Hologic Suisse SA, Hologic Surgical Products Costa Rica S.R.L., Hologic Sweden AB, Hologic Taiwan Ltd., Hologic UK Finance Ltd., Hologic US Finance Co LLC, Interlace Medical, Mobidiag Oy, Mobidiag Oy., Mobidiag UK Ltd., NXT-Dx SCRL, Navigation Three Limited, R2 Technology, Sentinelle Medical, Somatex (HK) Limited, Somatex Medical Technologies GmbH, Somatex Medical Technologies GmbH., Somatex USA Inc., SuperSonic Imagine (Shanghai) Medical Devices Co. Ltd., SuperSonic Imagine GmbH, SuperSonic Imagine HK Ltd, SuperSonic Imagine Ltd, SuperSonic Imagine SA, SuperSonic Imagine Srl, Suros Surgical Systems, Suros Surgical Systems Inc., TCT International, TCT International Co. Ltd., Third Wave Technologies, and Tridaho LLC.
Read More
This page (NASDAQ:HOLX) was last updated on 2/25/2024 by MarketBeat.com Staff